Feb-21-19 11:06AM | Is Eagle Pharmaceuticals, Inc.s (NASDAQ:EGRX) ROE Of 15% Impressive? Simply Wall St. |
10:31AM | Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for Zacks |
Feb-19-19 04:30PM | Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019 Business Wire |
Feb-18-19 10:30AM | Earnings Preview: Eagle Pharmaceuticals (EGRX) Q4 Earnings Expected to Decline Zacks |
Feb-14-19 09:10AM | Should Value Investors Buy Eagle Pharmaceuticals (EGRX) Stock? Zacks |
Jan-04-19 06:51AM | Does Eagle Pharmaceuticals, Inc.s (NASDAQ:EGRX) CEO Pay Matter? Simply Wall St. +5.67% |
Jan-02-19 07:00AM | Eagle Pharmaceuticals, Inc. to Present at 37th Annual J.P. Morgan Healthcare Conference Business Wire |
Dec-16-18 10:49PM | Hedge Funds Are Selling Eagle Pharmaceuticals Inc (EGRX) Insider Monkey |
Nov-30-18 07:45AM | Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire |
Nov-27-18 06:50AM | Eagle Pharmaceuticals Announces Positive Results of Pre-clinical Study Conducted to Evaluate Effects of RYANODEX in Acute Radiation Syndrome (ARS) Business Wire |
Nov-26-18 09:05AM | Investors Are Undervaluing Eagle Pharmaceuticals Inc (NASDAQ:EGRX) By 28.8% Simply Wall St. |
Nov-19-18 07:00AM | Eagle Pharmaceuticals, Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference Business Wire |
Nov-16-18 04:32AM | Moving Average Crossover Alert: Eagle Pharmaceuticals (EGRX) Zacks |
Nov-07-18 11:10AM | Edited Transcript of EGRX earnings conference call or presentation 1-Nov-18 12:30pm GMT Thomson Reuters StreetEvents |
Nov-01-18 10:41AM | Eagle Pharmaceuticals (EGRX) Q3 Earnings Match Estimates Zacks +6.07% |
08:21AM | Eagle Pharmaceuticals: 3Q Earnings Snapshot Associated Press |
06:50AM | Eagle Pharmaceuticals, Inc. Reports Third Quarter 2018 Results Business Wire |
Oct-30-18 06:50AM | Eagle Pharmaceuticals Commences $50 Million Accelerated Share Repurchase as Part of New $150 Million Share Repurchase Authorization Business Wire -16.52% |
06:45AM | Eagle Pharmaceuticals Announces Results of Study for Fulvestrant Business Wire |
Oct-25-18 05:00PM | Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2018 Financial Results on November 1, 2018 Business Wire |
Oct-23-18 07:25AM | Market Trends Toward New Normal in IAC/InterActiveCorp, Eagle Pharmaceuticals, Arrowhead Pharmaceuticals, The Manitowoc, Brookdale Senior Living, and LATAM Airlines Group S.A Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
Oct-19-18 09:28AM | Is Eagle Pharmaceuticals Inc (NASDAQ:EGRX) Attractive At Its Current PE Ratio? Simply Wall St. |
Oct-03-18 07:00AM | Eagle Pharmaceuticals Enters into Agreement with USAMRICD to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure Business Wire |
Sep-27-18 07:00AM | Eagle Pharmaceuticals, Inc. To Present At Cantor Global Healthcare Conference Business Wire |
Sep-26-18 04:30PM | Eagle Appoints David Pernock to Position of Chief Operating Officer Business Wire |
Sep-11-18 10:41AM | Does Eagle Pharmaceuticals Inc (NASDAQ:EGRX) Fall With The Market? Simply Wall St. |
Sep-07-18 08:32AM | Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod Zacks |
Sep-05-18 10:21AM | Agios (AGIO) Assigns Ex-Celgene Executive to CEO Position Zacks |
Sep-04-18 04:30PM | Eagle Pharmaceuticals, Inc. to Present at Morgan Stanley 16th Annual Global Healthcare Conference Business Wire |
Aug-30-18 07:00AM | Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat Stroke Business Wire -16.28% |
Aug-28-18 07:30AM | Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire |
Aug-23-18 07:00AM | Eagle Pharmaceuticals Named to Fortune 100 List of Fastest-Growing Companies Business Wire |
Aug-22-18 09:02AM | Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA Business Wire |
Aug-20-18 03:34PM | Edited Transcript of EGRX earnings conference call or presentation 7-Aug-18 12:30pm GMT Thomson Reuters StreetEvents |
Aug-07-18 08:15AM | Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Top Estimates Zacks |
07:09AM | Eagle Pharmaceuticals: 2Q Earnings Snapshot Associated Press |
06:50AM | Eagle Pharmaceuticals, Inc. Reports Second Quarter 2018 Results Business Wire |
06:30AM | Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE |
Aug-06-18 11:21AM | Emergent (EBS) Q2 Earnings and Revenues Surpass Estimates Zacks |
Aug-02-18 11:47AM | Conatus' (CNAT) Q2 Loss Narrows, Revenues Lag Marginally Zacks |
Jul-31-18 08:53AM | NuVasive (NUVA) in Focus: Stock Moves 6.02% Higher Zacks |
Jul-30-18 09:30AM | Is Eagle Pharmaceuticals (EGRX) Stock Outpacing Its Medical Peers This Year? Zacks |
Jul-25-18 07:00AM | Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Business Wire |
Jul-09-18 07:00AM | FDA Grants Eagle Seven Year Orphan Drug Exclusivity for BENDEKA (bendamustine hydrochloride injection) Business Wire |
Jul-03-18 08:30AM | Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA Business Wire |
Jun-29-18 07:30AM | Investor Expectations to Drive Momentum within Education Realty Trust, Eagle Pharmaceuticals, Boingo Wireless, United Parcel Service, Marathon Petroleum, and Coherent Discovering Underlying Factors of Influence GlobeNewswire |
Jun-11-18 09:32AM | Benzinga Pro's 5 Stocks To Watch Today Benzinga |
06:50AM | Court Issues Decision in Favor of Eagle Pharmaceuticals Granting Seven Year Orphan Drug Exclusivity for BENDEKA (bendamustine hydrochloride injection) Business Wire |
May-29-18 04:30PM | Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June Business Wire |
May-18-18 07:40AM | Wired News FDA Granted Approval to Eagle Pharmas Bendamustine Hydrochloride RTD Solution in a 500ml Admixture ACCESSWIRE |
May-17-18 07:50AM | Market Trends Toward New Normal in Agios Pharmaceuticals, Corcept Therapeutics, Prestige Brand, Virtu Financial, Eagle Pharmaceuticals, and Century Aluminum Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
May-16-18 06:50AM | Eagle Pharmaceuticals, Inc. Granted Final FDA Approval for Bendamustine Hydrochloride Ready-to-Dilute Solution in a 500ml Admixture Business Wire |
May-13-18 05:46AM | Edited Transcript of EGRX earnings conference call or presentation 10-May-18 12:30pm GMT Thomson Reuters StreetEvents |
May-10-18 07:11AM | Eagle Pharmaceuticals: 1Q Earnings Snapshot Associated Press |
06:50AM | Eagle Pharmaceuticals, Inc. Reports First Quarter 2018 Results Business Wire |
May-02-18 05:11AM | New Strong Sell Stocks for May 2nd Zacks |
May-01-18 04:30PM | Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2018 Financial Results on May 10, 2018 Business Wire |
Apr-30-18 04:30PM | Eagle Pharmaceuticals, Inc. to Present at 43rd Annual Deutsche Bank Health Care Conference Business Wire |
Apr-16-18 07:00AM | Eagle Pharmaceuticals Vasopressin ANDA Accepted for Filing by the FDA Business Wire |
Mar-27-18 08:30AM | Eagle Pharmaceuticals Announces New Patent for Eagle Biologics Business Wire |
Mar-06-18 07:10AM | Blog Exposure - Mylan Plans to Launch Two New HIV Treatments in the US ACCESSWIRE |
Mar-01-18 07:42AM | New Strong Sell Stocks for March 1st Zacks |
Feb-27-18 10:55AM | Eagle Pharmaceuticals (EGRX) Q4 2017 Earnings Conference Call Transcript Motley Fool -6.30% |
Feb-26-18 10:16PM | Edited Transcript of EGRX earnings conference call or presentation 26-Feb-18 1:30pm GMT Thomson Reuters StreetEvents -8.88% |
08:10AM | Recent Analysis Shows Valmont Industries, Guidewire Software, Eagle Pharmaceuticals, Bojangles', INVESCO MORTGAGE CAPITAL INC, and Archrock Partners Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire |
07:35AM | Eagle Pharmaceuticals posts 4Q profit Associated Press |
06:50AM | Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2017 Results Business Wire |
06:00AM | Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE |
Feb-15-18 04:30PM | Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Year End 2017 Financial Results on February 26, 2018 Business Wire +5.14% |
Feb-12-18 04:30PM | Eagle Pharmaceuticals, Inc. to Present at 2018 RBC Capital Markets Global Healthcare Conference Business Wire |
Feb-07-18 07:30AM | Eagle Pharmaceuticals Announces Fifth Orange Book Listed Patent for RYANODEX Business Wire |
Jan-02-18 08:07AM | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc. Markit +8.97% |
06:50AM | Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference Business Wire |
Dec-28-17 12:04PM | ETFs with exposure to Eagle Pharmaceuticals, Inc. : December 28, 2017 Capital Cube |
Dec-27-17 08:47AM | Eagle Pharmaceuticals, Inc. :EGRX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube |
Dec-21-17 07:14AM | Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : EGRX-US : December 21, 2017 Capital Cube |
Dec-19-17 08:00AM | Research Report Identifies 2U, AK Steel Holding, American Water Works, Urban Edge Properties, Guidewire Software, and Eagle Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
Dec-15-17 07:13PM | Cramer's lightning round: Buy Cisco when it goes below $3... CNBC Videos |
Dec-07-17 06:50AM | Eagle Pharmaceuticals Commences Pivotal Study for Fulvestrant Business Wire |
Nov-27-17 08:05AM | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc. Markit |
Nov-20-17 04:30PM | Eagle Pharmaceuticals, Inc. to Present at 29th Annual Piper Jaffray Healthcare Conference Business Wire |
Nov-16-17 09:01PM | Barron's After Hours: Splunk Surges, 21st Century Fox Jumps, Eagle Pharmaceuticals Plunges Barrons.com |
08:36PM | Edited Transcript of EGRX earnings conference call or presentation 8-Nov-17 1:30pm GMT Thomson Reuters StreetEvents |
Nov-15-17 08:06AM | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc. Markit |
Nov-10-17 01:10PM | Eagle Pharmaceuticals, Inc. Value Analysis (NASDAQ:EGRX) : November 10, 2017 Capital Cube |
Nov-09-17 07:21AM | Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : EGRX-US : November 9, 2017 Capital Cube -7.21% |
Nov-08-17 10:44AM | Eagle Pharmaceuticals posts 3Q profit Associated Press |
06:50AM | Eagle Pharmaceuticals, Inc. Reports Third Quarter 2017 Results Business Wire |
06:10AM | Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE |
Nov-07-17 04:30PM | Eagle Pharmaceuticals, Inc. to Present at Jefferies 2017 London Healthcare Conference Business Wire |
Oct-30-17 04:30PM | Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2017 Financial Results on November 8, 2017 Business Wire -6.52% |
Oct-27-17 04:44PM | Eagle Pharma gets tentative FDA approval for Lilly's Alimta version Reuters |
03:14PM | FDA tentatively approves Eagle Pharma's cancer drug Reuters |
03:02PM | Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute Business Wire |
Oct-24-17 09:37AM | ETFs with exposure to Eagle Pharmaceuticals, Inc. : October 24, 2017 Capital Cube |
Oct-17-17 07:33AM | Eagle Pharmaceuticals Announces New Patent for RYANODEX Business Wire |
Oct-15-17 12:00PM | 3 Biotech Values in a Fully Valued Market TheStreet.com |
Oct-13-17 10:44AM | ETFs with exposure to Eagle Pharmaceuticals, Inc. : October 13, 2017 Capital Cube |
Oct-11-17 08:23AM | Eagle Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : EGRX-US : October 11, 2017 Capital Cube |
Oct-02-17 10:49AM | ETFs with exposure to Eagle Pharmaceuticals, Inc. : October 2, 2017 Capital Cube |